These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14749546)

  • 1. The effect of parenteral nutrition fluids on the binding of therapeutic drugs to human serum in vitro.
    Bailey DN; Briggs JR
    Ther Drug Monit; 2004 Feb; 26(1):31-4. PubMed ID: 14749546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of coadministered drugs and ethanol on the binding of therapeutic drugs to human serum in vitro.
    Bailey DN
    Ther Drug Monit; 2001 Feb; 23(1):71-4. PubMed ID: 11206047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative binding of therapeutic drugs by sera of seven mammalian species.
    Bailey DN
    J Anal Toxicol; 1998; 22(7):587-90. PubMed ID: 9847009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The binding of selected therapeutic drugs to human serum alpha-1 acid glycoprotein and to human serum albumin in vitro.
    Bailey DN; Briggs JR
    Ther Drug Monit; 2004 Feb; 26(1):40-3. PubMed ID: 14749548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of free drug monitoring.
    Dasgupta A
    Clin Chem Lab Med; 2002 Oct; 40(10):986-93. PubMed ID: 12476936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative binding of acetaminophen, lidocaine, phenobarbital, phenytoin, quinidine, and theophylline to human tissues in vitro.
    Bailey DN
    J Anal Toxicol; 1997; 21(1):1-4. PubMed ID: 9013284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of amino-acid fluids on drug binding to site II of human serum albumin in vitro.
    Yamasaki K; Kuga N; Takamura N; Furuya Y; Hidaka M; Iwakiri T; Nishii R; Okumura M; Kodama H; Kawai K; Arimori K
    Biol Pharm Bull; 2005 Mar; 28(3):549-52. PubMed ID: 15744089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in protein binding of drugs in plasma and serum.
    Ohshima T; Hasegawa T; Johno I; Kitazawa S
    Clin Chem; 1989 Aug; 35(8):1722-5. PubMed ID: 2503268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of microultrafiltration devices for determination of protein binding.
    Ohshima T; Johno I; Kitazawa S
    Ther Drug Monit; 1988; 10(3):310-5. PubMed ID: 3176109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug interferences with plasma assays in therapeutic drug monitoring.
    Yosselson-Superstine S
    Clin Pharmacokinet; 1984; 9(1):67-87. PubMed ID: 6362953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid: in vitro plasma protein binding and interaction with phenytoin.
    Cramer JA; Mattson RH
    Ther Drug Monit; 1979; 1(1):105-16. PubMed ID: 121944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for monitoring free drug levels.
    Levy RH; Moreland TA
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():1-9. PubMed ID: 6705421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug protein binding in chronic renal failure: evaluation of nine drugs.
    Vanholder R; Van Landschoot N; De Smet R; Schoots A; Ringoir S
    Kidney Int; 1988 May; 33(5):996-1004. PubMed ID: 3392889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do evacuated blood collection tubes interfere with therapeutic drug monitoring?
    Janknegt R; Lohman JJ; Hooymans PM; Merkus FW
    Pharm Weekbl Sci; 1983 Dec; 5(6):287-90. PubMed ID: 6664820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of a new automated substrate-labeled fluorescence immunoassay system evaluated by comparative therapeutic monitoring of five drugs.
    Klotz U
    Ther Drug Monit; 1984; 6(3):355-9. PubMed ID: 6390798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Displacement of valproic acid and carbamazepine from protein binding in normal and uremic sera by tolmetin, ibuprofen, and naproxen: presence of inhibitor in uremic serum that blocks valproic acid-naproxen interactions.
    Dasgupta A; Volk A
    Ther Drug Monit; 1996 Jun; 18(3):284-7. PubMed ID: 8738769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption of therapeutic drugs by barrier gels in serum separator blood collection tubes. Volume- and time-dependent reduction in total and free drug concentrations.
    Dasgupta A; Dean R; Saldana S; Kinnaman G; McLawhon RW
    Am J Clin Pathol; 1994 Apr; 101(4):456-61. PubMed ID: 8160636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum protein binding of tolbutamide in patients treated with antiepileptic drugs.
    Fernández MC; Erill S; Lucena MI; Pita E; Pérez-Alférez N
    Clin Pharmacokinet; 1985; 10(5):451-5. PubMed ID: 3930124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of disease states on plasma protein binding of drugs.
    Reidenberg MM
    Med Clin North Am; 1974 Sep; 58(5):1103-9. PubMed ID: 4607741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.